APA

Eldehna W. M., Abou-Seri S. M., El Kerdawy A. M., Ayyad R. R., Hamdy A. M., Ghabbour H. A., Ali M. M. & Abou El Ella D. A. (20161213). Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives. : European journal of medicinal chemistry.

Chicago

Eldehna Wagdy M, Abou-Seri Sahar M, El Kerdawy Ahmed M, Ayyad Rezk R, Hamdy Abdallah M, Ghabbour Hazem A, Ali Mamdouh M and Abou El Ella Dalal A. 20161213. Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives. : European journal of medicinal chemistry.

Harvard

Eldehna W. M., Abou-Seri S. M., El Kerdawy A. M., Ayyad R. R., Hamdy A. M., Ghabbour H. A., Ali M. M. and Abou El Ella D. A. (20161213). Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives. : European journal of medicinal chemistry.

MLA

Eldehna Wagdy M, Abou-Seri Sahar M, El Kerdawy Ahmed M, Ayyad Rezk R, Hamdy Abdallah M, Ghabbour Hazem A, Ali Mamdouh M and Abou El Ella Dalal A. Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives. : European journal of medicinal chemistry. 20161213.